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Ethylene diamine tetraacetic acid (EDTA) is
a chelating agent which has been used in the
treatment of a number of seemingly unrelated
conditions, all pertaining to the removal of a
heavy metal from the body (1—6). Chelating
agents have the ability to combine with metallic
ions rendering the metal no longer available for
its usual reactions. The chelate thus formed is
excreted unchanged in the urine (6, 7).
EDTA has no reported effect on the peripheral
blood flow or skin. However, it was administered
intravenously to three cases of scleroderma by
Rukavina, et al (8) with considerable subjective
and objective improvement in the skin and
osseous findings. During the course of therapy
in two of these cases it was noted that the ex-
tremities seemed warmer. However, peripheral
vascular studies such as skin temperature meas-
urements, histamine wheal and oscillometry, dem-
onstrated that no statistically significant changes
occurred between the before and after com-
parisons.
A patient with scieroderma involving primarily
the hands and forearms and with Raynaud's
phenomenon was treated with EDTA by one of
us (RHL). It was observed that her extremities
appeared warmer and more moist during infusions
with 3.0 grams of EDTA. This patient's skin also
appeared more pliable after 2—3 weeks of this
therapy. Because of these observations a more
intensive study of both this patient and of normal
individuals was undertaken to assess the periph-
eral vascular effects of intravenously administered
EDTA.
METHODS
Five subjects, four men and one woman, with
no clinically detectable vascular disease were
chosen. Their ages ranged from 24—50 years.
The sixth subject, the patient with scleroderma,
was 34 years of age. A constant temperature
room was employed and the temperature was
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maintained at 22° C 1° C for the 6 subjects.
The patient with scieroderma was also studied
in a room at 25° C 1° C. Skin temperatures
at multiple sites were recorded continuously
using iron-constantan thermocouples. A record
of the oral temperature was also obtained. Toe
and finger flows were measured by the method
of Simeone (9) with amplification of the oscilla-
tions in the recording machine (Grass). Hand
blood flows, measured in our patient with scle-
roderma, were determined using a hand plethys-
mograph as previously described (10). Blood
pressure measurements were made by ausculta-
tion intermittently throughout the procedure.
The subjects were allowed to adapt to the room
for approximately 30 minutes. The protocol was
thoroughly explained in an attempt to minimize
anxiety and control measurements were obtained.
Two and one-half grams of EDTA, * diluted in
1000 cc. 5% D/W, was started intravenously.
The rate of administration varied, beginning
slowly and then increasing to considerably faster
speeds. Frequent blood flow determinations were
made. When very rapid rates of infusion were
shown to produce no changes in the circulation
being studied the drip was slowed then stopped
and follow-up determinations were made. The
total dose of drug administered ranged from 0.44
to 1.25 grams. Urinary Sulkowitch tests were
done on 24 hour urine collections before, during
and after the experiment.
RESULTS AND DISCUSSION
No significant clinical effects were noted during
the administration of EDTA to the 5 normal
subjects. Two subjects complained of pain along
the course of the vein receiving the infusion when
at a rapid rate of administration. This subsided
promptly upon slowing the rate. No flushing,
sweating or increased warmth was noted in any
of these subjects.
Finger and toe cutaneous temperatures and
finger and toe blood flows in the five normal
* Supplied as Endrate Disodium by Abbott
Laboratories, North Chicago, Ill.
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TABLE 1
Mean blood flow (cc./100 cc/mm.)
Before EDTA During EDTA 4 HoursAfter EDTA
Finger Toe Finger Toe Finger Toe
J. C.
K. B.
H.Z.
E. D.
J. 0.
3.3
3.3
10.4
6.6
7.9
.83
.55
1.10
.65
.33
2.0
1.2
9.8
10.2
13.1
.35
.51
.56
.75
.54
6.9
2.5
.69
.41
The mean blood flow, to the finger and toe, in
cc./100 cc. tissue/minute demonstrates no signifi-
cant changes during EDTA administration. One
of the two subjects restudied 4 hours after the
infusion showed a distinct rise in finger circula-
tion.
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subjects demonstrated no significant changes
during EDTA administration. Two of the five
subjects were restudied 4 hours after the infusion
was stopped and in one of them a higher finger
blood flow was demonstrated at this time. Table
1 is a chart of the mean blood flow to the finger
and toe of each subject before and during an
infusion containing EDTA and includes the mean
circulation to finger and toe of the two subjects
restudied 4 hours later. Figure 1 is a graph of the
finger and toe blood flows and skin temperatures
during an EDTA infusion in one of our subjects.
The female patient with scleroderma and
Raynaud's phenomenon, when studied as the
above subjects, demonstrated significant increase
in the flows to the hand, finger, thumb and toe.
This patient was studied on 4 occasions. The
most pronounced augmentation of peripheral
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Fin. 1. Graphs showing the changes in the skin temperature and blood flow of a finger and toe of one
of the normal subjects before and during EDTA administration and four hours after the end of the
infusion. No significant effects were noted.
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blood flow occurred towards the end of the 5
hour infusion when she had received almost 3.0
grams of EDTA. Table 2 shows the mean blood
flows before and towards the termination of the
_________________________________
EDTA infusion. On each study a definite increase
in circulation to the parts measured was noted.
Her pulse volumes were also observed to be
decidedly raised and her skin more moist than
before the treatment started. Skin temperature
values of the fingers and toes also rose corre-
spondingly with the increase in blood flow to the
0.9 parts. The measurement of blood flow to the
1.74 thumb, finger and hand in this case was com-
plicated by the thin tight skin over these areas,
thereby diminishing the reservoir into which
venous blood can expand. This fact makes the
observed elevations in flow more striking.
The explanation of the difference in response
between this patient and the 5 normal subjects
is unknown to us. It is possible that the normal
subjects would have shown some augmentation
-
CONTROL MEASUREMENTS 5 HOURS LATER
FIG. 2. Blood flow and skin temperature changes in patient with scieroderma. These rises were ac-
companied by a subjective and objective warmth as well as perspiration of the hands.
TABLE 2
Mean blood flow (cc./100 cc/mire.)
During
EDTA
Infusion
Hand Toe
.38 .41
At the End of
a 5 Hour
EDTA Infusion
Thumb Toe
L. G.
4/21
4/22
4/30
5/1
Before EDTA
Hand Toe
0 .28
Thumb
1.65 .51
4.33 .55
Finger
.77 .08
6.75
5.32
Finger
2.7
The mean blood flow in cc./100 cc. tissue/
minute to the distal extremities demonstrates a
decided increase towards the end of a 5 hour in-
fusion containing 3.0 grams EDTA in a patient
with scieroderma.
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of peripheral blood flow if they had been studied
over a more prolonged period of time. Also, the
change observed does not necessarily indicate an
increased circulation to the extremity but could
havc been due to the skin of the patient with
scleroderma becoming more pliable in some
manner. Or non-specific action may have oc-
curred or a combination of factors may have
accounted for the observed changes. Figure 2
is a graph demonstrating the skin temperature
and blood flow changes noted during an EDTA
infusion in our patient with scleroderma.
No consistent changes in urinary calcium were
noted in any of the subjects.
SUMMARY
EDTA was administered by the intravenous
route to 5 subjects to study the effect on the
peripheral blood flow. No significant changes in
finger or toe skin temperatures or blood flows
could be demonstrated. However, in a patient
with moderately advanced scleroderma EDTA
infusion was shown to produce a significant
increase in measured blood flow to the finger,
thumb, hand and toe. The reason for this dif-
ference is unknown but may relate to a number of
different factors noteworthy of which is a possible
non-specific loosening of the integument, thereby
enabling truer measurements of peripheral blood
flow.
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